Long-term effects of child cancer treatment

Awras Majeed discusses the Late Effects Assessment Programme (LEAP) in New Zealand, a national service providing long-term surveillance for young people who have completed childhood cancer treatment.

Topics

Intro.
Play now
Late Effects Assessment Programme (LEAP).
Play now
Are all kids completing cancer treatment added to the programme?
Play now
Common late effects to be aware of.
Play now
Late term effects of Radiotherapy.
Play now
Other long term effects
Play now
National LEAP Passport
Play now
Common childhood cancers
Play now
Does high dose chemotherapy equal higher risk of recurrence?
Play now
Psychological presentations
Play now
How common are long term effects?
Play now
Fertility preserving approaches.
Play now
Oral health effects.
Play now
First clinic appointment in primary care.
Play now
high risk groups to be aware of.
Play now
hand over process and GP responsibilities.
Play now
Take-home messages
Play now

Take home messages

Thinking about late effects can feel negative - Important to say most survivors live healthy and happy lives.
Treatment is less toxic - Survivors now live longer.
Cancer type, age of diagnosis and treatment received are important for determining long-term late effects.
Radiation is the main factor in the risk of second malignancy. Screening is important.
As their GP you might be the first person to have a conversation about fertility.
The LEAP passport will outline everything about ongoing surveillance.

Presenter

Awras Majeed

Consultant Paediatrician

Awras is a Consultant Generalist Paediatrician working at Matatiki Child and Youth Health in Waitaha Canterbury. She is a Member of the National Child Cancer Network, working with the Late Effects Assessment Programme (LEAP).